CVE-2020-10534
Description
From CVE.org
In the GlobalBlocking extension before 2020-03-10 for MediaWiki through 1.34.0, an issue related to IP range evaluation resulted in blocked users re-gaining escalated privileges. This is related to the case in which an IP address is contained in two ranges, one of which is locally disabled.
Common Vulnerability Scoring System (CVSS) Score Details
Info alert:Important note
CVSS scores for open source components depend on vendor-specific factors (e.g. version or build chain). Therefore, Red Hat's score and impact rating can be different from NVD and other vendors. Red Hat remains the authoritative CVE Naming Authority (CNA) source for its products and services (see Red Hat classifications).
The following CVSS metrics and score provided are preliminary and subject to review.
CVSS v3 Score Breakdown
| Red Hat | NVD | cve.org | |
|---|---|---|---|
| Base Score | 8.1 | 9.8 | N/A |
| Attack Vector | Network | Network | N/A |
| Attack Complexity | High | Low | N/A |
| Privileges Required | None | None | N/A |
| User Interaction | None | None | N/A |
| Scope | Unchanged | Unchanged | N/A |
| Confidentiality | High | High | N/A |
| Integrity Impact | High | High | N/A |
| Availability Impact | High | High | N/A |
Vector
Red Hat: CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
NVD: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Red Hat CVSS v3 Score Explanation
This vulnerability in the GlobalBlocking extension leads to configured IP blocking rules failing to enforce the denied ranges. However, to bypass this enforcement anyway a potential attacker can use proxies, port forwarding or IP spoofing to circumvent such protections anyway.
Understanding the Weakness (CWE)
Access Control
Technical Impact: Gain Privileges or Assume Identity
A user can access restricted functionality and/or sensitive information that may include administrative functionality and user accounts.
Frequently Asked Questions
Not sure what something means? Check out our Security Glossary.
Want to get errata notifications? Sign up here.